Literature DB >> 19651784

C1q tumor necrosis factor alpha-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase.

Seung-Yoon Park1, Jung Hyun Choi, Hyun Su Ryu, Youngmi Kim Pak, Kyong Soo Park, Hong Kyu Lee, Wan Lee.   

Abstract

Depletion of mtDNA in myocytes causes insulin resistance and alters nuclear gene expression that may be involved in rescuing processes against cellular stress. Here we show that the expression of C1q tumor necrosis factor alpha-related protein isoform 5 (C1QTNF5) is drastically increased following depletion of mtDNA in myocytes. C1QTNF5 is homologous to adiponectin in respect to domain structure, and its expression and secretion from myocytes correlated negatively with the cellular mtDNA content. Similar to adiponectin, C1QTNF5 induced the phosphorylation of AMP-activated protein kinase (AMPK), leading to increased cell surface recruitment of GLUT4 and increased glucose uptake. Treatment of cells with purified recombinant C1QTNF5 increased the phosphorylation of acetyl-CoA carboxylase and stimulated fatty acid oxidation. C1QTNF5-mediated phosphorylation of AMPK or acetyl-CoA carboxylase was unaffected by depletion of adiponectin receptors such as AdipoR1 or AdipoR2, which indicated that adiponectin receptors do not participate in C1QTNF5-induced activation of AMPK. Serum C1QTNF5 levels were significantly higher in obese/diabetic animals (OLETF rats, ob/ob mice, and db/db mice). These results highlight C1QTNF5 as a putative biomarker for mitochondrial dysfunction and a potent activator of AMPK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651784      PMCID: PMC2788828          DOI: 10.1074/jbc.M109.005611

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.

Authors:  Eva Tomas; Tsu-Shuen Tsao; Asish K Saha; Heather E Murrey; Cheng cheng Zhang Cc; Samar I Itani; Harvey F Lodish; Neil B Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

3.  C1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen.

Authors:  Gerald Lasser; Prasenjit Guchhait; Jeff L Ellsworth; Paul Sheppard; Ken Lewis; Paul Bishop; Miguel A Cruz; Jose A Lopez; Joachim Fruebis
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

4.  Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle.

Authors:  Jong-Yeon Kim; Timothy R Koves; Geng-Sheng Yu; Tod Gulick; Ronald N Cortright; G Lynis Dohm; Deborah M Muoio
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-05       Impact factor: 4.310

Review 5.  The AMP-activated protein kinase cascade--a unifying system for energy control.

Authors:  David Carling
Journal:  Trends Biochem Sci       Date:  2004-01       Impact factor: 13.807

6.  Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration.

Authors:  Caroline Hayward; Xinhua Shu; Artur V Cideciyan; Alan Lennon; Perdita Barran; Sepideh Zareparsi; Lindsay Sawyer; Grace Hendry; Baljean Dhillon; Ann H Milam; Philip J Luthert; Anand Swaroop; Nicholas D Hastie; Samuel G Jacobson; Alan F Wright
Journal:  Hum Mol Genet       Date:  2003-08-27       Impact factor: 6.150

7.  A family of Acrp30/adiponectin structural and functional paralogs.

Authors:  Guang W Wong; Jin Wang; Christopher Hug; Tsu-Shuen Tsao; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

8.  A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation.

Authors:  Romel Somwar; Sandra Koterski; Gary Sweeney; Richard Sciotti; Stevan Djuric; Cathy Berg; James Trevillyan; Philipp E Scherer; Christina M Rondinone; Amira Klip
Journal:  J Biol Chem       Date:  2002-10-21       Impact factor: 5.157

9.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

10.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.

Authors:  Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Atsushi Tsuchida; Takehiko Yokomizo; Shunbun Kita; Takuya Sugiyama; Makoto Miyagishi; Kazuo Hara; Masaki Tsunoda; Koji Murakami; Toshiaki Ohteki; Shoko Uchida; Sato Takekawa; Hironori Waki; Nelson H Tsuno; Yoichi Shibata; Yasuo Terauchi; Philippe Froguel; Kazuyuki Tobe; Shigeo Koyasu; Kazunari Taira; Toshio Kitamura; Takao Shimizu; Ryozo Nagai; Takashi Kadowaki
Journal:  Nature       Date:  2003-06-12       Impact factor: 49.962

View more
  44 in total

1.  C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway.

Authors:  Qijun Zheng; Yuexing Yuan; Wei Yi; Wayne Bond Lau; Yajing Wang; Xiaoliang Wang; Yang Sun; Bernard L Lopez; Theodore A Christopher; Jonathan M Peterson; G William Wong; Shiqiang Yu; Dinghua Yi; Xin-Liang Ma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

2.  Is erythroferrone finally the long sought-after systemic erythroid regulator of iron?

Authors:  Alfons Lawen
Journal:  World J Biol Chem       Date:  2015-08-26

3.  174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy.

Authors:  Joseph Fogerty; Joseph C Besharse
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-14       Impact factor: 4.799

4.  Lipogenesis in myoblasts and its regulation of CTRP6 by AdipoR1/Erk/PPARγ signaling pathway.

Authors:  Wenjing Wu; Yunmei Sun; Chen Zhao; Cunzhen Zhao; Xiaochang Chen; Guoqiang Wang; Weijun Pang; Gongshe Yang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-04-28       Impact factor: 3.848

5.  A CTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degeneration.

Authors:  Venkata R M Chavali; Naheed W Khan; Catherine A Cukras; Dirk-Uwe Bartsch; Monica M Jablonski; Radha Ayyagari
Journal:  Hum Mol Genet       Date:  2011-02-24       Impact factor: 6.150

6.  Chondrocyte-specific ablation of Osterix leads to impaired endochondral ossification.

Authors:  Jung-Hoon Oh; Seung-Yoon Park; Benoit de Crombrugghe; Jung-Eun Kim
Journal:  Biochem Biophys Res Commun       Date:  2012-01-21       Impact factor: 3.575

7.  Metabolic regulation by C1q/TNF-related protein-13 (CTRP13): activation OF AMP-activated protein kinase and suppression of fatty acid-induced JNK signaling.

Authors:  Zhikui Wei; Jonathan M Peterson; G William Wong
Journal:  J Biol Chem       Date:  2011-03-04       Impact factor: 5.157

8.  C1q/tumor necrosis factor-related protein 11 (CTRP11), a novel adipose stroma-derived regulator of adipogenesis.

Authors:  Zhikui Wei; Marcus M Seldin; Niranjana Natarajan; David C Djemal; Jonathan M Peterson; G William Wong
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

9.  Ets-2 is involved in transcriptional regulation of C1qTNF-related protein 5 in muscle cells.

Authors:  Eun-Ju Park; Mi-Jin Kim; Wan Lee; Seung-Yoon Park
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

Review 10.  Metabolic function of the CTRP family of hormones.

Authors:  Marcus M Seldin; Stefanie Y Tan; G William Wong
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.